NOW APPROVED: EMROSI™ (Minocycline Hydrochloride) Extended-Release Capsules, 40mg
| Date | Form | Description | XBRL | Pages | |
|---|---|---|---|---|---|
| 09/19/23 | 8-K | Current report filing |
|
|
2 |
| 09/08/23 | 4 | Statement of changes in beneficial ownership of securities |
|
1 | |
| 09/08/23 | 4 | Statement of changes in beneficial ownership of securities |
|
1 | |
| 09/06/23 | 8-K | Current report filing |
|
|
4 |
| 08/18/23 | 8-K | Current report filing |
|
|
2 |
| 08/10/23 | 10-Q | Quarterly report pursuant to Section 13 or 15(d) |
|
|
95 |
| 08/08/23 | 8-K | Current report filing |
|
|
7 |
| 07/26/23 | 8-K | Current report filing |
|
|
2 |
| 07/25/23 | 4 | Statement of changes in beneficial ownership of securities |
|
1 | |
| 07/25/23 | 4 | Statement of changes in beneficial ownership of securities |
|
1 |




